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Introduction
Genome editing belongs to a category of cutting-edge modern technologies that have assumed a 
totemic importance for some politicians and policy advisors as, urged on by futurologists and business 
executives, they contemplate the emerging disruptions of the ‘Fourth Industrial Revolution’ (4IR). Other 
technologies that have been associated with 4IR include nanotechnology, big data and machine-
learning, self-driving vehicles, stem-cell therapies and laboratory-cultured artificial meat.
Genome editing is a technique of genetic engineering that involves the alteration of an organism’s 
genetic structure by adding, deleting, changing or replacing individual nucleotides or sequences of 
DNA.1 Also known as gene editing, it comprises several different methods and tools, which can be  
used to alter the traits of crop plants and livestock animals (see GEAP3 Briefing 1).2 
The truth is that nobody really knows how technologies like these might change industries, economies 
and societies in the coming decades, but everyone seems to agree that emerging technologies 
will have – or are already having – a transformational impact. So how should societies be preparing 
themselves to engage with genome editing and its products in the domains of food and agriculture, 
including all the possible opportunities, risks, advantages and costs which they present?
This briefing collates key insights arising from desk-based research and an expert dialogue which was 
convened during October 2020 by the policy hub of the GEAP3 network,3 to discuss the governance 
of genome editing applications in agriculture, especially in crop breeding. The dialogue events focused 
on policy and regulatory questions for the European Union (EU) and the United Kingdom (UK) in 
the context of their trade relationships with each other and with third countries, especially in North 
America and sub-Saharan Africa. 
This briefing identifies the major themes arising from the dialogue and documentary sources, and sets 
out a number of outstanding questions for policy. 
1 DNA stands for deoxyribonucleic acid, a type of molecule often referred to as the genetic ‘building blocks’ of life.
2 GEAP3 Briefing 1: ‘Genome Editing in Agriculture: Issues for Policy and Regulation’ (available via geap3.com/policy-hub) 
3 See geap3.com and the details at the end of this briefing.
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Some scientific advisory bodies and lobby groups 
have urged European governments to facilitate 
the early and rapid deployment of genome editing 
in agricultural as well as medical applications 
(see Box). A genome-editing technique known 
as CRISPR (see GEAP3 Briefing 1) has been 
heralded by scientists and business leaders as an 
opportunity to develop improved crop varieties 
more quickly and reliably. This is often described 
as a chance to meet pressing challenges such as 
climate change, global food security and a more 
sustainable agriculture.
Making way for genome editing
4 ALLEA – All European Academies, 2020. Genome Editing for Crop Improvement. Symposium Report. Berlin, DE: ALLEA – All European Academies. 
https://allea.org/wp-content/uploads/2020/10/ALLEA_Gen_Editing_Crop_2020.pdf 
5 Leopoldina National Science Academy, German Research Foundation and the Union of German Academies of Science, 2019. Stellungnahme: Wege zu 
einer wissenschaftlich begründeten,differenzierten Regulierung genomeditierter Pflanzen in der EU | Towards a scientifically justified, differentiated 
regulation of genome edited plants in the EU. Berlin, DE: Nationale Akademie der Wissenschaften Leopoldina, Deutsche Forschungsgemeinschaft and 
Union der deutschen Akademien der Wissenschaften. https://www.leopoldina.org/uploads/tx_leopublication/2019_Stellungnahme_Genomeditierte_
Pflanzen_web_02.pdf (Quotation taken from the English-language short version of the statement.)
6 EUSAGE, no date. Regulating genome-edited organisms as GMOs has negative consequences for agriculture, society and economy. Position paper. 
European Sustainable Agriculture through Genome Editing (EUSAGE). https://www.eu-sage.eu/sites/default/files/2020-02/Position%20paper%20
on%20the%20ECJ%20ruling.pdf
Scientific bodies and lobby groups call for regulatory changes  
to enable rapid deployment of genome editing in agriculture
 “leading scientists representing 
European plant and life sciences 
research centres and institutes 
endorsed a position paper to urge 
European policy makers to take 
action in order to facilitate the 
potential of genome editing for 
agriculture, in Europe.”
ALLEA – All European Academies, 
20204
 “the science academies and 
the DFG see an urgent need to 
reassess the products of the 
much more precise and efficient 
methods of genome editing and 
to amend European genetic 
engineering law.”
Leopoldina National Science 
Academy, German Research 
Foundation and the Union of German 
Academies of Science, 20195
 “Subjecting crops obtained 
through modern genome editing 
to GMO regulations will deny 
European consumers, producers, 
researchers and entrepreneurs 
important opportunities 
in sustainable agriculture. 
Therefore, an urgent review and 
amendment of the European 
legislation on new breeding 
technologies is needed.”
EUSAGE – European Sustainable 
Agriculture through Genome Editing, 
no date6 
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Other stakeholders are concerned that novel 
technologies that can be applied to positive ends 
can also be used in ways that do not produce 
broad benefits for society or the environment. 
They highlight problems in modern agriculture 
that stem from previous rounds of technological 
innovation. Even if modern farming technologies 
and methods have led to positive outcomes, such 
as increased global production of some major 
food crops, they have also generated various 
undesirable consequences, such as air and water 
pollution, soil erosion, greenhouse gases, and 
declining biodiversity.
Participants in debates about genome editing also 
look back at experiences with transgenic crops 
(a previous generation of genetic engineering 
applied to plant breeding, often known as 
genetically modified or GM crops). These were 
intended to make crops resistant to pests and 
diseases, increase crop yields, provide farmers 
with more convenient and financially efficient crop 
management options, and improve the nutritional 
composition of food crops.
However, some of these promised crops have not 
yet seen the light of day, and among those that 
have been commercialised are GM crops that have 
been associated with accumulating problems. 
Crops that were designed to withstand herbicides, 
which were supposed to assist farmers with weed 
control, have been associated with a very large 
increase in the use of the chemicals, leading to 
the development of an increasing number of 
herbicide-resistant types of weeds that are more 
difficult and expensive for farmers to control. In 
some cases, GM crops that were given built-in 
defences against insect pests have stimulated the 
evolution of insect populations that can withstand 
the pesticidal toxins that the plants have been 
engineered to produce.
The genetic engineers’ solutions to these new 
problems often involve more genetic engineering, 
to develop new types of GM crops that incorporate 
resistance to several different kinds of herbicides, 
and express multiple toxic proteins that kill insect 
pests in different ways. Critics contend that this 
amounts to an arms race – a technology treadmill, 
which draws farmers into ever higher costs and 
deepening dependence on the agri-business 
companies that supply the new technologies. 
If genome editing ends up entrenching and 
intensifying this dynamic, they say, then it will not 
do much to help address the urgent challenge of 
achieving a more ecologically and economically 
sustainable agriculture, especially over the  
longer term.
Proponents of genome editing, including some 
who participated in our dialogue events, say that 
the new techniques are more sophisticated, which 
will enable molecular plant breeders to generate 
new crops with complex and valuable traits, such 
as drought tolerance, that have proved difficult 
to develop using GM technology. They argue 
that CRISPR is an essential tool for achieving 
sustainable and resilient agriculture and tackling 
climate change within the next few years.
Other participants in our dialogue events 
questioned this contention. Just because genome 
editing offers a new way to snip and splice genetic 
material, they said, does not mean that scientists 
have yet mastered understanding, or controlling, 
the expression of complex genetic traits in living 
organisms and real environments.
The critics worry that genetic engineers, when 
talking to policy makers and the public, advertise 
speculative future benefits of CRISPR while 
downplaying uncertainties that are discussed in 
the scientific literature, and focus only on narrowly 
defined risks and safety issues without attending 
to larger concerns about the social, economic and 
environmental purposes and impacts of genome 
editing in agriculture.
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CRISPR is often described as a very precise 
technique, but the attribute of precision can 
convey different meanings to different audiences.
Technically, precision in CRISPR refers to the 
way the tool can be targeted to cut an intended 
location in the genome, where it can make small 
changes which affect a 
small number of base-pairs 
of DNA. In their precision, 
CRISPR and other genome-
editing tools have been 
compared favourably to 
the previous generation of 
transgenic techniques, which 
incorporated genetic material randomly into an 
unpredictable site within the host genome (see 
GEAP3 Briefing 1). 
The exactness of genome editing at a molecular 
scale has been taken to imply that CRISPR also 
provides certainty and control at larger scales. 
According to this view, CRISPR is as safe as, or 
even safer than, previous techniques of transgenic 
and conventional breeding, because it involves 
genetic alterations that are more deliberate, more 
predictable, and easier to verify and monitor. 
Policy makers, politicians and media pundits have 
picked up on this message that CRISPR is safer, 
and this seems to be influencing debates about the 
appropriate regulations to govern genome editing 
and its products.
However, critics dispute the inference that 
molecular precision also means safety on the 
levels of the organism, ecology and society. These 
critics make their case in a 
number of ways. They point 
to scientific reports in which 
CRISPR was found to have 
created unintended changes 
in genomes, both at the 
target location and in non-
target areas. They remind 
stakeholders about the degrees of uncertainty 
that still remain in genetic engineering, in spite 
of advances in scientific knowledge. They urge 
scientists and regulators to take explicit account 
of epigenetics, which can change the expression of 
genetic traits, in ways that are heritable, without 
corresponding changes in the underlying DNA; 
and pleiotropy, which is the ability of genes to 
influence the expression of more than one trait. 
They argue that ongoing uncertainty about 
the operations and effects of these biological 
mechanisms implies a continuing need for careful 
and cautious regulation of genome-edited 
organisms on a case-by-case basis.
Precision means control?
CRISPR is often described as  
a very precise technique, but  
the attribute of precision can 
convey different meanings to 
different audiences.
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Some molecular biologists argue that the existence 
of unintended effects is not a cause for alarm or a 
justification for strict regulations. They point out 
that multiple random mutations are apt to occur 
in living organisms without any direct human 
intervention, and are common in conventional 
crop breeding. They also point to the decades-
long safe use of mutation 
breeding, which works by 
exposing genetic material to 
radiation or chemicals, and 
can also produce multiple 
random mutations at one 
time. Compared to these 
changes, say these scientists, 
the deliberate alteration of 
one or a handful of genes 
represents a very small 
risk. They explain that crop 
developers typically carry 
out genetic screening and 
other checks to ensure that 
the changes created through genome editing are 
as intended, and have not produced negative side-
effects (see GEAP3 Briefing 1). Overall, supporters 
of genome editing assess the risks posed by 
genome editing to be small in proportion to the 
advantages, which are quantifiable in terms of time 
saved and financial resources conserved.
Other stakeholders doubt whether the genetic 
mutations generated by genome editing, 
mutation breeding and traditional cross-breeding 
techniques are really as well understood as 
supporters claim. They wonder whether it is 
safe to assume that genetic changes that are 
generated by quite different processes of genetic 
modification are essentially similar, or if that 
hypothesis should be tested 
scientifically (and if so, how 
that testing would be done).
After a genetic alteration 
has been generated using 
genome-editing tools, 
the processes that occur 
afterwards still depend 
on some basic principles 
of genetics and rely upon 
some traditional breeding 
techniques. The molecular 
breeder must still contend 
with uncertainty over how 
genetic changes at the molecular level will affect 
the expression of plant traits. The uncertainty 
arises from epigenetics and pleiotropy, and 
from the potential for changes in DNA to lead to 
unpredictable changes in RNA, or at the levels of 
protein expression (proteomics) or metabolism 
(metabolomics). These effects need to be analysed 
and fine-tuned before a viable cultivar is ready 
for release to farmers, and regulations may also 
Should we worry?
[Some experts find that] consumers 
and citizens seem to weigh the 
risks and safety of novel genetic 
technologies against the purposes 
for which they are applied, as well 
as the size and distribution of the 
social and environmental benefits 
they could generate. Answering 
these societal questions could be 
the most important challenge for the 
promoters of genome-edited crops. 
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require this to be done. These steps still take 
time, even if the process of genetic alteration at 
molecular level, using genome editing tools, is 
relatively quick.
Genetic marker-assisted breeding techniques  
have already helped to accelerate conventional 
plant breeding methods, enabling breeders to 
quickly develop useful and commercially valuable 
new traits without the help of genetic engineering. 
This leads some observers to doubt whether 
the speed advantages of the CRISPR tool for 
plant breeding are as decisive and compelling, in 
practical and economic terms, as some genetic 
engineers believe.
With these thoughts in mind, is CRISPR technology 
as revolutionary, in its practical utility, as some 
scientists assert? In the words of one participant in 
our expert dialogue, “Where are the ‘killer apps’?” 
The doubters want to see evidence that new 
genome-edited crop varieties will really enable 
farmers to achieve a step-change in sustainable 
productivity, resource-use efficiency, or other 
desirable objectives, or do so any quicker than 
other methods of crop improvement.
Participants in our expert dialogue noted that 
this kind of circumspection is often echoed by 
members of the public when they participate in 
public dialogues, consultations and focus groups: 
consumers and citizens seem to weigh the risks 
and safety of novel genetic technologies against 
the purposes for which they are applied, as well 
as the size and distribution of the social and 
environmental benefits they could generate. 
Answering these societal questions could be the 
most important challenge for the promoters of 
genome-edited crops. 
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Another topic of discussion, which genome editing 
has inherited from earlier debates about GM 
crops, is the potential for genetically engineered 
and ‘conventional’ crops to co-exist. If farmers or 
consumers wish to exercise an individual choice to 
accept or reject genetic engineering technologies, 
is it feasible for different production systems 
to operate, comfortably, 
side-by-side in the same 
landscapes and markets? 
If the two systems cannot 
exist in close proximity 
without creating friction, 
are governance measures 
available that could allow stakeholders to  
pursue their private interests without coming  
into conflict?
It has been argued that systems of liability and 
insurance could incentivise users of genome-
edited crops to keep their operations from 
harming neighbours who are non-users, and 
resolve disputes fairly and equitably. But for what 
kinds of ‘harm’ would liability arise, and what forms 
of compensation would be appropriate  
and effective?
Some participants in our expert dialogue were 
concerned that calls from industry and scientists 
to deregulate genome-edited crops are ignoring 
the problems of co-existence. They worry that 
complete deregulation would mean that farmers 
and consumers who want to avoid genetically 
engineered crops would be denied the freedom 
to do so, or would be 
burdened with all the costs 
of keeping genome edited 
and non-genome edited 
crops separate. On the 
other hand, supporters of 
genome-editing object to 
systems of regulation that place burdens of liability 
on farmers who want to grow the new crops, and 
require genome-edited foods to be segregated 
and labelled. They believe that such measures are 
not justified by an objective risk of harm, yet they 
discourage the use of a technology that could 
generate broad benefits for society and  
the environment.
Co-existence and freedom to operate
Is it feasible for different production 
systems to operate, comfortably, 
side-by-side in the same 
landscapes and markets?
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Stakeholders who support a liberalisation of 
rules governing genome editing in agriculture 
argue that the costs of excessive regulation 
should be weighed alongside the costs that 
arise from insufficient regulation. A commonly 
heard criticism of the way GMOs have been 
governed is that regulations have made the cost 
of commercialising a new GM crop so high that it 
has only been accessible to large companies with 
deep pockets, and only attractive for large-scale, 
industrial farming applications in the world’s most 
commercially important crops.
This argument is not confined exclusively to 
scientists who support the rapid liberalisation of 
genetic engineering applications, including new 
genome-edited crops. Various other stakeholders, 
including some civil society groups, environmental 
campaigners and small-farm organisations, 
agree that new regulations are needed which 
could support the development of modern 
biotechnologies by smaller firms and public-sector 
breeders, to create solutions for neglected ‘orphan 
crops’, small-scale farms, narrow agro-ecological 
niches, and for more diverse kinds of agriculture.
Another area of regulation is intellectual property. 
Some stakeholders are concerned that transgenic 
organisms and enabling technologies can be 
patented, which often has the effect of limiting 
access to technologies and germplasm by public 
and non-profit breeders. Also, university science 
has become more dependent on corporate 
research funding. Some contributors to our 
dialogue held the opinion that patent protection is 
inappropriate for technologies that are in principle 
cheap and easy to use, so that they can be used to 
develop new commercial products quickly.
According to this argument, in such cases, there 
is no need for patent protection to incentivise 
the large and long-term investments needed 
to support slow and costly research and 
development. The argument implies that, since 
CRISPR is widely hailed as a simple and affordable 
technology, it would not be appropriate to 
protect genome-editing tools with intellectual 
property rights.7 This argument also carries the 
implication that it would be regrettable if stringent 
safety regulations were then to impede the rapid 
commercialisation of useful new technologies.
Better regulation
7 Another consideration is whether it will be possible to detect genome-edited organisms and distinguish them from organisms that have been 
developed using other mutation-breeding techniques; if not, patents might prove to be hard to enforce anyway (see GEAP3 Briefing 1).
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Some contributors to our dialogue expressed 
scepticism about the idea that simply deregulating 
genome-edited crops and foods would 
automatically lead to the development of socially 
and environmentally valuable products. Profit-
driven commercial actors typically prioritise 
private benefits and short-term rewards over 
public goods and long-
term benefits. A different 
mechanism is needed to 
promote innovation in the 
public interest. Some of our 
dialogue participants are 
involved in promoting policy 
frameworks for ‘responsible 
research and innovation’ 
(RRI), which aim to ensure 
that societal goals are more likely to be achieved.
A legal expert who participated in our dialogue 
raised an objection to the notion that regulators 
should require product developers to demonstrate 
a broad social benefit before their genome-
edited crops and foods could be permitted. The 
principled argument behind this objection was 
that, in a liberal society, individuals and companies 
were, or should be, free to pursue private interests, 
regardless of whether their activities benefit 
wider society. Underlying liberal-democratic 
constitutions is a presumption that private actors 
may apply technologies 
to secure private benefits, 
provided they are not doing 
immediate harm to others.
The policy challenge that 
arises here is whether such 
a laissez-faire principle 
provides a sound basis for the 
responsible governance of 
novel technologies’ wider impacts and long-term 
effects, especially insidious negative impacts that 
are not perceived until later, or which externalise 
costs inequitably onto society or certain 
communities.
Societal benefits and public goods
Profit-driven commercial actors 
typically prioritise private benefits 
and short-term rewards over public 
goods and long-term benefits. A 
different mechanism is needed  
to promote innovation in the  
public interest.
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The Precautionary Principle (PP) is a principle of 
technology governance which aims to guide policy 
makers towards responsible decision-making in 
contexts of scientific uncertainty. Critics of the 
PP say that it is an ‘anti-innovation’ or even an 
‘anti-science’ principle. However, when properly 
applied, it is better understood as a principle that 
should help to steer innovation towards socially 
useful and beneficial purposes. The point is that 
the PP encourages innovation in the light of careful 
reflection about the purposes and benefits to 
be realised. Taking risks under uncertainty can 
be justified, transparently, if the purposes and 
benefits are substantial enough to merit the risk, 
and if precautions are taken to avoid, monitor and 
mitigate harm.
While some scientists have called for the PP to be 
rejected, more moderate scientific voices accept 
that a precautionary approach is appropriate 
where there is genuine scientific uncertainty. 
However, they point out that a proper application 
of the PP requires mechanisms to review and 
revise precautionary measures as scientific 
uncertainty diminishes. One participant in our 
expert dialogue captured this spirit when they 
called for the PP to be complemented with “post-
cautionary” reviews. These reviews would create 
an ‘exit strategy’ from precautionary regulations 
when scientific understanding improves, and 
evidence accumulates which indicates that risks 
and hazards are small. According to this approach, 
governments should systematically revisit 
precautionary laws after an appropriate period, 
assess the performance and impacts of previous 
regulatory choices, and revise them appropriately.
Precaution, post-caution?
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How should societies and governments proceed 
with genome editing? Opting for light-touch 
regulation of genome editing applications across 
the board would imply that accelerating the 
adoption of these technologies is an intrinsically 
desirable thing to do. From this optimistic 
viewpoint, new technologies like genome editing 
can be assumed a priori to lead, on balance or 
in aggregate or eventually, to outcomes that 
are socially, economically 
and ecologically positive 
and sustainable. However, 
technologies of many 
kinds can be and have been 
applied for deplorable as 
well as benign purposes; 
they may be used to advance 
private agendas that are not 
necessarily in the public 
interest; and they can be 
deployed in pursuit of short-
term and local advantages 
while producing serious, enduring and highly 
consequential problems at larger spatial and 
temporal scales. Assuming that rapid innovation 
and technological change are intrinsically good 
and desirable things is naïve, ahistorical and 
potentially reckless.
Innovation optimists often argue that, without 
the technological innovations of the past, human 
society would be a lot worse off today. People who 
ask sceptical questions about genome editing and 
other cutting-edge innovations are sometimes 
portrayed as luddites with a poor grasp of history, 
who underestimate the benefits of the numerous 
modern technologies that underpin human 
wellbeing today.
Since the industrial revolution and the dawn 
of scientific breeding, technological change in 
agricultural methods and 
practices has indeed driven 
a huge transformation of 
farming and food systems. 
However, it is also undeniable 
that modern, intensive 
farming methods have been 
associated with serious 
environmental and social 
problems, including erosion 
and salination of soils, 
chemical pollution of air and 
water bodies, the destruction 
of biodiversity, draining of water reserves, 
unsustainable consumption of fossil fuels, large 
contributions to greenhouse gas emissions, 
homogenisation of global diets and the persistence 
of hunger and under-nutrition alongside diseases 
associated with obesity and overweight.
Neglecting to consider problems like these, 
including their links to historical innovations in 
agricultural technologies and methods, reflects 
Proceeding responsibly with novel technologies
The challenge, for governments 
and society, as they consider what 
to do about genome editing in 
agriculture, is to balance competing 
priorities, steer innovation, take 
responsible decisions in the light of 
uncertainty, consider ramifications 
and alternative scenarios, and take 
care over the distribution of costs, 
benefits and risks.
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a common flaw in reasoning. It displays a kind 
of survivorship bias, whereby it is assumed that 
whatever happened in the past must have been 
beneficial, on balance, since those of us who are 
alive today are evidence that the good choices 
and decisions of our ancestors allowed our 
technologically sophisticated modern society to 
survive and prosper.
This seductive and plausible argument contains 
a logical flaw. It systematically ignores and 
devalues all the things that were lost along the 
way. It downplays the new problems which our 
technological trajectories have generated, albeit 
unintentionally or through ignorance. It overlooks 
the possibilities that existed at times in the past 
to do things differently; to choose alternative 
technological paths, and to achieve different 
outcomes, which might even have been better 
than those we enjoy today.
We know that agriculture faces many challenges 
in the current century and that new and existing 
technologies will need to be employed in new ways 
to meet them. The challenge, for governments and 
society, as they consider what to do about genome 
editing in agriculture, is to balance competing 
priorities, steer innovation, take responsible 
decisions in the light of uncertainty, consider 
ramifications and alternative scenarios, and take 
care over the distribution of costs, benefits  
and risks.
Some participants in our expert dialogue shared 
the view that it would be essential to bring a wide 
cross-section of society into the conversation, in 
order to deliberate over the distribution of costs, 
benefits and risks for different people, groups 
and interests. The scope should embrace socio-
economic as well as biophysical risks, and the 
interests of future generations as well as those 
currently alive. It should consider how to generate 
public goods (as well as how these should be 
defined and assessed), not just private benefits. 
It should weigh the costs of inaction as well as of 
action. A frank appreciation of uncertainty should 
be at the centre when considering both risks  
and benefits.
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Here are some questions for European and other policy makers and decision 
makers to consider, relating to the future governance of genome editing in 
agriculture and food.
Questions for policy and decision making
 If the regulations applied to (some) genome edited organisms differ from  
the rules applied to transgenic organisms (GMOs) in agriculture and food, 
what principled grounds will explain and justify the difference in treatment? 
Will the rules distinguish between different types of genome-edited 
organisms according to whether the final product contains transgenes, 
and/or the magnitude of genetic changes made (see GEAP Briefing 1)? 
How will the grounds used to draw such distinctions be clearly defined, 
articulated and defended to stakeholders and publics?
 Will policies and regulatory frameworks governing genome editing in  
crop improvement take account of the proposed social purposes and 
plausible public benefits that could be attained using general or specific 
applications of the technology? If such intended purposes and future 
benefits are to influence regulatory decisions, how could they be assessed 
and weighed against potential risks and harms? Could crop breeders be 
required to articulate or demonstrate a societal benefit in order to win 
regulatory clearance for their genome edited organisms? Would it be 
reasonable to require applicants to show that the proposed objectives  
could not be achieved economically or efficiently in other ways, without 
using genome editing?
 What accountability exists for making promises about the benefits 
of genome editing and its products? If the projected benefits do not 
materialise, or are unevenly distributed, or come with serious side-effects, 
who is accountable for that? If there is no effective accountability for such 
promissory statements, what value should policy makers give to them?
 Can we rely on the developers of genome-edited organisms, nationally  
and internationally, always to be responsible and conscientious in checking 
for unintended on- and off-target effects, and to identify risks and manage 
hazards that might arise from them? If we cannot rely solely on responsible 
behaviour by product developers, what regulatory measures could provide 
assurance that developers are not taking unreasonable or disproportionate 
risks or exposing others to unacceptable harm? Could a regime of liability 
and redress, underpinned by insurance, play a role here?
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 To what extent, if at all, should considerations of international trade 
influence policy and decision making on genome editing in agriculture? 
What would be the implications of regulatory non-alignment, in relation to 
genome edited organisms, for trade and other international relationships 
(such as international development aid and technical cooperation)? How can 
or should policy makers and regulators in Europe work with international 
partners to co-ordinate regulatory processes, decision making and 
outcomes for genome editing that will promote sustainable and resilient 
agriculture, food security, and other desirable objectives across borders  
and at a global scale?
 Will public and consumer values and attitudes be taken explicitly into 
account in the design of regulatory frameworks, or in the approval process 
for specific applications of genome editing in agriculture and food? 
How could public concerns be included transparently and effectively in 
deliberations that lead to decisions?
 How will the Precautionary Principle and the principles of Responsible 
Research and Innovation inform the governance and regulation of genome 
editing in agriculture and food?
 Does the proper interpretation of the PP entail that the implementation of 
precautionary rules should be followed by regular ‘post-cautionary’ reviews, 
which would allow regulations to be revised when scientific uncertainty 
diminishes? Is it possible for regulatory protocols to define a point when 
research, having sought but failed to identify or discover negative effects, 
provides sufficient evidence to provide confidence that risks and hazards 
are absent, or small enough, to justify full or partial deregulation?
 Will the governance framework for genome editing in food and agriculture 
allow both ‘genetically engineered’ organisms and ‘conventional’ crop 
production systems to co-exist, both on farms and in markets? How could 
this be accomplished in practice?
The GEAP3 Project Policy Hub
The Genome Editing and Agriculture: Policy, Practices and Public Perceptions (GEAP3) network is an 
international research consortium that brings together social scientists, policy experts and bio-scientists to 
explore the domestic and international ramifications of the EU’s policy and regulatory approach to genome 
editing in agriculture. The network is exploring and analysing key developments in genome editing and their 
implications for agriculture through three hubs: policy, practice, and public perceptions.
The GEAP3 Policy hub has explored systematically the implications of the EU’s regulatory approach to  
genome editing. The hub examined how competing visions for the governance of genome editing conflict  
or may be reconciled.
The work of the GEAP3 network is continuing in the Practices and Public Perceptions hubs.  
For further information on the GEAP3 network and its three hubs, please visit the project website at  
https://www.geap3.com
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